References
- Wissel J, Manack A, Brainin M. Toward an epidemiology of poststroke spasticity. Neurology. 2013;80( Issue 3, Supplement 2):S13–9.
- Platz T, Wissel J, Donauer E, et al. [S2k-guideline: treatment of spastic syndrome. DGNeurology]. German 2019. [cited 2021 Nov 06]. Available from: https://doi.org/https://doi.org/10.1007/s42451-019-0090-2** recent update of the management of spastic movement disorder
- Wissel J, Schelosky LD, Scott J, et al. Early development of spasticity following stroke: a prospective, observational trial. J Neurol. 2010;257(7):1067–1072. DOI:https://doi.org/10.1007/s00415-010-5463-1.
- Urban PP, Wolf T, Uebele M, et al. Occurrence and clinical predictors of spasticity after ischemic stroke. Stroke. 2010;41(9):2016–2020. DOI:https://doi.org/10.1161/STROKEAHA.110.581991.
- Wissel J, Verrier M, Simpson DM, et al., Post-stroke spasticity: predictors of early development and considerations for therapeutic intervention. PM R. 2015;7(1):60–67. https://doi.org/10.1016/j.pmrj.2014.08.946. .
- Hotter B, Padberg I, Liebenau A, et al. Identifying unmet needs in long-term stroke care using in-depth assessment and the Post-Stroke Checklist – the Managing Aftercare for Stroke (MAS-I) study. Eur Stroke J. 2018;3(3):237–245. DOI:https://doi.org/10.1177/2396987318771174.
- Pandyan AD, Gregoric M, Barnes MP, et al., Spasticity: clinical perceptions, neurological realities and meaningful measurement. Disabil Rehabil. 2005;27(1–2):2–6. https://doi.org/10.1080/09638280400014576. .
- Fheodoroff K, Kossmehl P, Wissel J. Validity and reliability of the spasticity-associated arm pain scale. J Pain Manag Med. 2017;3(2):127.
- Kivi A, Ri S, Wissel J. What clinicians and patients want: the past, the presence, and the future of the botulinum toxins. Toxicon. 2020;177:46–51.
- Dressler D, Bhidayasiri R, Bohlega S, et al. Defining spasticity: a new approach considering current movement disorders terminology and botulinum toxin therapy. J Neurol. 2018;265(4):856–862. DOI:https://doi.org/10.1007/s00415-018-8759-1.
- Francisco GE, Li S. Spasticity Cifu, David X. In: Physical medicine and rehabilitation. 5th ed. Philadelphia, USA: Elsevier; 2015. 488–510 .
- Gracies JM. Pathophysiology of spastic paresis. I: paresis and soft tissue changes. Muscle Nerve. 2005;31(5):535–551.
- Lindsay C, Ispoglou S, Helliwell B, et al. Can the early use of botulinum toxin in post stroke spasticity reduce contracture development? A randomized controlled trial. Clin Rehabil. 2021;35(3):399–409. DOI:https://doi.org/10.1177/0269215520963855.
- Glaess-Leistner S, Ri SJ, Audebert HJ, et al. Early clinical predictors of post stroke spasticity. Top Stroke Rehabil. 2021;28(7):508–518. DOI:https://doi.org/10.1080/10749357.2020.1843845.
- Hesse S, Mach H, Frohlich S, et al. An early botulinum toxin a treatment in subacute stroke patients may prevent a disabling finger flexor stiffness six months later: a randomized controlled trial. Clin Rehabil. 2012;26(3):237–245. DOI:https://doi.org/10.1177/0269215511421355.
- Rosales RL, Efendy F, Teleg ES, et al. Botulinum toxin as early intervention for spasticity after stroke or non-progressive brain lesion: a meta-analysis. J Neurol Sci. 2016;371:6–14.
- Demetrios M, Khan F, Turner-Stokes L, et al. Multidisciplinary rehabilitation following botulinum toxin and other focal intramuscular treatment for post-stroke spasticity. Cochrane Database Syst Rev. 2013;6:CD009689.
- Picelli A, Santamato A, Cosma M, et al. Early botulinum toxin type a injection for post-stroke spasticity: a longitudinal cohort study. Toxins (Basel). 2021;13(6):374. DOI:https://doi.org/10.3390/toxins13060374.
- Bernhardt J, Hayward KS, Kwakkel G, et al. Agreed definitions and a shared vision for new standards in stroke recovery research: the stroke recovery and rehabilitation roundtable taskforce. Neurorehabil Neural Repair. 2017;31(9):793–799. DOI:https://doi.org/10.1177/1545968317732668.
- Salter K, Jutai J, Hartley M, et al. Impact of early vs delayed admission to rehabilitation on functional outcomes in persons with stroke. J Rehabil Med. 2006;38(2):113–117. DOI:https://doi.org/10.1080/16501970500314350.
- Francisco GE, McGuire JR. Poststroke spasticity management. Stroke. 2012;43(11):3132–3136.
- Picelli A, Tamburin S, Dambruoso F, et al. Topical distribution of initial paresis of the limbs to predict clinically relevant spasticity after ischemic stroke: a retrospective cohort study. Eur J Phys Rehabil Med. 2014;50(5):489–494.
- Picelli A, Tamburin S, Gajofatto F, et al. Association between severe upper limb spasticity and brain lesion location in stroke patients. Biomed Res Int. 2014;2014:162754.
- Sommerfeld DK, Eek EU, Svensson AK, et al. Spasticity after stroke: its occurrence and association with motor impairments and activity limitations. Stroke. 2004;35(1):134–139. DOI:https://doi.org/10.1161/01.STR.0000105386.05173.5E.
- Lee KB, Hong BY, Kim JS, et al. Which brain lesions produce spasticity? An observational study on 45 stroke patients. PLoS One. 2019;14(1):e0210038. DOI:https://doi.org/10.1371/journal.pone.0210038.
- Ri S, Kivi A, Urban PP, et al. Site and size of lesion predict post-stroke spasticity: a retrospective magnetic resonance imaging study. J Rehabil Med. 2020;52(5):jrm00065. DOI:https://doi.org/10.2340/16501977-2665.
- Ri S, Glaess-Leistner S, Wissel J. Early brain imaging predictors of post-stroke spasticity. J Rehabil Med. 2021;53(3):jrm00169.
- Kellor M, Frost J, Silberberg N, et al. Hand strength and dexterity. Am J Occup Ther. 1971;25(2):77–83.
- Ri S, Glaess-Leistner S, Wissel J, et al. Why the nine hole peg test should not disappear from clinical stroke routine. Int J Cerebrovasc Dis Stroke. 2021;4:131.
- Bavikatte G, Subramanian G, Ashford S, et al. Early identification, intervention and management of post-stroke spasticity: expert consensus recommendations. J Cent Nerv Syst Dis. 2021;13:11795735211036576.
- Sunnerhagen KS. Predictors of spasticity after stroke. Curr Phys Med Rehabil Rep. 2016;4(3):182–185.
- Opheim A, Danielsson A, Alt Murphy M, et al. Early prediction of long-term upper limb spasticity after stroke: part of the SALGOT study. Neurology. 2015;85(10):873–880. DOI:https://doi.org/10.1212/WNL.0000000000001908.
- Wilkinson D, Sakel M, Camp S-J, et al. Patients with hemispatial neglect are more prone to limb spasticity, but this does not prolong their hospital stay. Arch Phys Med Rehabil. 2012;93(7):1191–1195. DOI:https://doi.org/10.1016/j.apmr.2012.01.010.
- Taylor-Rowan M, Wilson A, Dawson J, et al. Functional assessment for acute stroke trials: properties, analysis, and application. Front Neurol. 2018;9:191.
- Meyer MJ, Pereira S, McClure A, et al. A systematic review of studies reporting multivariable models to predict functional outcomes after post-stroke inpatient rehabilitation. Disabil Rehabil. 2015;37(15):1316–1323. DOI:https://doi.org/10.3109/09638288.2014.963706.
- Harrison JK, McArthur KS, Quinn TJ. Assessment scales in stroke: clinimetric and clinical considerations. Clin Interv Aging. 2013;8:201–211.
- Turner-Stokes L, Ashford S, Esquenazi A, et al. A comprehensive person-centered approach to adult spastic paresis: a consensus-based framework. Eur J Phys Rehabil Med. 2018;54(4):605–617. DOI:https://doi.org/10.23736/S1973-9087.17.04808-0.
- Choudhry S, Patritti BL, Woodman R, et al. Goal attainment: a clinically meaningful measure of success of botulinum toxin-a treatment for lower limb spasticity in ambulatory patients. Arch Rehabil Res Clin Transl. 2021;3(2):100129. DOI:https://doi.org/10.1016/j.arrct.2021.100129.
- Turner-Stokes L, Baguley IJ, De Graaff S, et al., Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: a secondary analysis from a double-blind placebo-controlled randomized clinical trial. J Rehabil Med. 2010;42(1):81–89. https://doi.org/10.2340/16501977-0474. .
- Wissel J, Ward AB, Erztgaard P, et al. European consensus table on the use of botulinum toxin type a in adult spasticity. J Rehabil Med. 2009;41(1):13–25. DOI:https://doi.org/10.2340/16501977-0303.
- Ashworth B. Preliminary trial of carisoprodol in multiple sclerosis. Practitioner. 1964;192:540–542.
- Bohannon RW, Smith MB. Interrater reliability of a modified Ashworth scale of muscle spasticity. Phys Ther. 1987;67(2):206–207.
- Tardieu G, Shentoub S, Delarue R. Research on a technique for measurement of spasticity. Rev Neurol (Paris). 1954;91(2):143–144. French.
- Penn RD, Savoy SM, Corcos D, et al. Intrathecal baclofen for severe spinal spasticity. N Engl J Med. 1989;320(23):1517–1521. DOI:https://doi.org/10.1056/NEJM198906083202303.
- Williamson A, Hoggart B. Pain: a review of three commonly used pain rating scales. J Clin Nurs. 2005;14(7):798–804.
- Huskisson EC. Measurement of pain. Lancet. 1974;2:1127–1131.
- Fröhlich-Zwahlen AK, Casartelli NC, Item-Glatthorn JF, et al. Validity of resting myotonometric assessment of lower extremity muscles in chronic stroke patients with limited hypertonia: a preliminary study. J Electromyogr Kinesiol. 2014;24(5):762–769. DOI:https://doi.org/10.1016/j.jelekin.2014.06.007.
- Posteraro F, Crea S, Mazzoleni S, et al. Technologically-advanced assessment of upper-limb spasticity: a pilot study. Eur J Phys Rehabil Med. 2018;54(4):536–544. DOI:https://doi.org/10.23736/S1973-9087.17.04815-8.
- Sinkjaer T, Magnussen I. Passive, intrinsic and reflex-mediated stiffness in the ankle extensors of hemiparetic patients. Brain. 1994;117(2):355–363.
- Kamper DG, Harvey RL, Suresh S, et al. Relative contributions of neural mechanisms versus muscle mechanics in promoting finger extension deficits following stroke. Muscle Nerve. 2003;28(3):309–318. DOI:https://doi.org/10.1002/mus.10443.
- Li S, Kamper DG, Rymer WZ. Effects of changing wrist positions on finger flexor hypertonia in stroke survivors. Muscle Nerve. 2006;33(2):183–190.
- Leng Y, Wang Z, Bian R, et al. Alterations of elastic property of spastic muscle with its joint resistance evaluated from shear wave elastography and biomechanical model. Front Neurol. 2019;10:736.
- Calota A, Feldman AG, Levin MF. Spasticity measurement based on tonic stretch reflex threshold in stroke using a portable device. Clin Neurophysiol. 2008;119(10):2329–2337.
- Levin MF, Feldman AG. The role of stretch reflex threshold regulation in normal and impaired motor control. Brain Res. 1994;657(1–2):23–30.
- Frenkel-Toledo S, Solomon JM, Shah A, et al. Tonic stretch reflex threshold as a measure of spasticity after stroke: reliability, minimal detectable change and responsiveness. Clin Neurophysiol. 2021;132(6):1226–1233. DOI:https://doi.org/10.1016/j.clinph.2021.02.390.
- Mugler EM, Tomic G, Singh A, et al. Myoelectric computer interface training for reducing co-activation and enhancing arm movement in chronic stroke survivors: a randomized trial. Neurorehabil Neural Repair. 2019;33(4):284–295. DOI:https://doi.org/10.1177/1545968319834903.
- Lagnau P, Lo A, Sandarage R, et al. Ergonomic recommendations in ultrasound-guided botulinum neurotoxin chemodenervation for spasticity: an international expert group opinion. Toxins (Basel). 2021;13(4):249. DOI:https://doi.org/10.3390/toxins13040249.
- Wu CH, Ho YC, Hsiao MY, et al. Evaluation of post-stroke spastic muscle stiffness using shear wave ultrasound elastography. Ultrasound Med Biol. 2017;43(6):1105–1111. DOI:https://doi.org/10.1016/j.ultrasmedbio.2016.12.008.
- Gao J, He W, Du LJ, et al. quantitative ultrasound imaging to assess the biceps brachii muscle in chronic post-stroke spasticity: preliminary observation. Ultrasound Med Biol. 2018;44(9):1931–1940. DOI:https://doi.org/10.1016/j.ultrasmedbio.2017.12.012.
- Moreta MC, Fleet A, Reebye R, et al. Reliability and validity of the modified heckmatt scale in evaluating muscle changes with ultrasound in spasticity. Arch Rehabil Res Clin Transl. 2020;2(4):100071. DOI:https://doi.org/10.1016/j.arrct.2020.100071.
- Francisco GE, Wissel J, Platz T, et al. Post-stroke spasticity. In: Platz T, editors. Clinical pathways in stroke rehabilitation. Cham: Springer; 2021. 149–173 .
- Platz T, Vuadens P, Eickhof C, et al. REPAS, a summary rating scale for resistance to passive movement: item selection, reliability and validity. Disabil Rehabil. 2008;30(1):44–53. DOI:https://doi.org/10.1080/09638280701191743.
- Meseguer-Henarejos AB, Sǎnchez-meca J, López-Pina JA, et al. Inter-and intra-rater reliability of the modified Ashworth scale: a systematic review and meta-analysis. Eur J Phys Rehabil Med. 2018;54(4):576–590. DOI:https://doi.org/10.23736/S1973-9087.17.04796-7.
- Abolhasani H, Ansari NN, Naghdi S, et al. Comparing the validity of the Modified Modified Ashworth Scale (MMAS) and the Modified Tardieu Scale (MTS) in the assessment of wrist flexor spasticity in patients with stroke: protocol for a neurophysiological study. BMJ Open. 2012;2(6):e001394. DOI:https://doi.org/10.1136/bmjopen-2012-001394.
- Banky M, Clark RA, Mentiplay BF, et al. Toward accurate clinical spasticity assessment: validation of movement speed and joint angle assessments using smartphones and camera tracking. Arch Phys Med Rehabil. 2019;100(8):1482–1491. DOI:https://doi.org/10.1016/j.apmr.2018.11.026.
- Wissel J, Ganapathy V, Ward AB, et al. Onabotulinumtoxin A improves pain in patients with post-stroke spasticity: findings from a randomized, double-blind, placebo-controlled trial. J Pain Symptom Manage. 2016;52(1):17–26. DOI:https://doi.org/10.1016/j.jpainsymman.2016.01.007.
- Lichtner V, Dowding D, Esterhuizen P, et al. Pain assessment for people with dementia: a systematic review of systematic reviews of pain assessment tools. BMC Geriatr. 2014;14(1):138. DOI:https://doi.org/10.1186/1471-2318-14-138.
- Tyson SF, Brown P. How to measure pain in neurological conditions? A systematic review of psychometric properties and clinical utility of measurement tools. Clin Rehabil. 2014;28(7):669–686.
- Ashford S, Fheodoroff K, Jacinto J, et al. Common goal areas in the treatment of upper limb spasticity: a multicentre analysis. Clin Rehabil. 2016;30(6):617–622. DOI:https://doi.org/10.1177/0269215515593391.
- Kiresuk TJ, Sherman RE. Goal attainment scaling: a general method for evaluating comprehensive community mental health programs. Community Ment Health J. 1968;4(6):443–453.
- Eftekhar P, Mochizuki G, Dutta T, et al. Goal attainment scaling in individuals with upper limb spasticity post stroke. Occup Ther Int. 2016;23(4):379–389. DOI:https://doi.org/10.1002/oti.1440.
- Fheodoroff K, Scheschonka A, Wissel J. Goal analysis in patients with limb spasticity treated with incobotulinumtoxin A in the TOWER study. Disabil Rehabil. 2020;1–7. DOI:https://doi.org/10.1080/09638288.2020.1804627
- Lawrence W, Black C, Tinati T, et al. ‘Making every contact count’: evaluation of the impact of an intervention to train health and social care practitioners in skills to support health behaviour change. J Health Psychol. 2016;21(2):138–151. DOI:https://doi.org/10.1177/1359105314523304.
- Black C, Lawrence W, Cradock S, et al. Healthy conversation skills: increasing competence and confidence in front-line staff. Public Health Nutr. 2014;17(3):700–707. DOI:https://doi.org/10.1017/S1368980012004089.
- Rockwood K, Ebly E, Hachinski V, et al. Presence and treatment of vascular risk factors in patients with vascular cognitive impairment. Arch Neurol. 1997;54(1):33–39. DOI:https://doi.org/10.1001/archneur.1997.00550130019010.
- Ashford S, Jackson D, Turner-Stokes L. Goal setting, using goal attainment scaling, as a method to identify patient selected items for measuring arm function. Physiotherapy. 2015;101(1):88–94.
- Brashear A, Gordon MF, Elovic E, Botox Post-Stroke Spasticity Study Group, et al. Intramuscular injection of botulinum toxin for the treatment of wrist and finger spasticity after a stroke. N Engl J Med. 2002;347(6):395–400.
- Andringa A, van de Port I, van Wegen E, et al. Effectiveness of botulinum toxin treatment for upper limb spasticity poststroke over different ICF domains: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2019;100(9):1703–1725. DOI:https://doi.org/10.1016/j.apmr.2019.01.016.
- Gracies JM, Brashear A, Jech R, et al. Safety and efficacy of Abobotulinumtoxin A for hemi-paresis in adults with upper limb spasticity after stroke or traumatic brain injury: a double-blind randomised controlled trial. Lancet Neurol. 2015;14(10):992–1001. DOI:https://doi.org/10.1016/S1474-4422(15)00216-1.
- Foley N, Pereira S, Salter K, et al. Treatment with botulinum toxin improves upper-extremity function post stroke: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2013;94(5):977–989. DOI:https://doi.org/10.1016/j.apmr.2012.12.006.
- Marciniak C, Munin MC, Brashear A, et al. Incobotulinumtoxin a efficacy and safety in adults with upper-limb spasticity following stroke: results from the open-label extension period of a phase 3 study. Adv Ther. 2019;36(1):187–199. DOI:https://doi.org/10.1007/s12325-018-0833-7.
- Dressler D, Altavista MC, Altenmueller E, et al., Consensus guidelines for botulinum toxin therapy: general algorithms and dosing tables for dystonia and spasticity. J Neural Transm (Vienna). 2021;128(3):321–335. https://doi.org/10.1007/s00702-021-02312-4. .
- Hallett M. Explanation of timing of botulinum neurotoxin effects, onset and duration, and clinical ways of influencing them. Toxicon. 2015;107:64–67.
- Wissel J, Bensmail D, Ferreira JJ, et al., Safety and efficacy of incobotulinumtoxin A doses up to 800 U in limb spasticity: the TOWER study. Neurology. 2017;88(14):1321–1328. https://doi.org/10.1212/WNL.0000000000003789. .
- Eleopra R, Tugnoli V, De Grandis D. The variability in the clinical effect induced by botulinum toxin type A: the role of muscle activity in humans. Mov Disord. 1997;12(1):89–94.
- Poulain B, de Paiva A, Dolly JO, et al. Differences in the temperature dependencies of uptake of botulinum and tetanus toxins in Aplysia neurons. Neurosci Lett. 1992;139(2):289–292. DOI:https://doi.org/10.1016/0304-3940(92)90573-P.
- Gracies J-M, Esquenazi A, Brashear A, et al. Efficacy and safety of abobotulinumtoxin A in spastic lower limb: randomized trial and extension. Neurology. 2017;89(22):2245–2253. DOI:https://doi.org/10.1212/WNL.0000000000004687.
- Xie HM, Guo TT, Sun X, et al. Effectiveness of botulinum toxin a in treatment of hemiplegic shoulder pain: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2021; 102 (9) ;1775–1787.
- Turkel CC, Bowen B, Liu J, et al. Pooled analysis of the safety of botulinum toxin type A in the treatment of poststroke spasticity. Arch Phys Med Rehabil. 2006;87(6):786–792. DOI:https://doi.org/10.1016/j.apmr.2006.02.015.
- Coté TR, Mohan AK, Polder JA, et al. Botulinum toxin type A injections: adverse events reported to the US Food and Drug Administration in therapeutic and cosmetic cases. J Am Acad Dermatol. 2005;53(3):407–415. DOI:https://doi.org/10.1016/j.jaad.2005.06.011.
- Rosales RL, Kong KH, Goh KJ, et al. Botulinum toxin injection for hypertonicity of the upper extremity within 12 weeks after stroke: a randomized controlled trial. Neurorehabil Neural Repair. 2012;26(7):812–821. DOI:https://doi.org/10.1177/1545968311430824.
- Simpson DM, Hallett M, Ashman EJ, et al. Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache report of the guideline development Subcommittee of the American Academy of neurology. Neurology. 2016;86(19):1818–1826. DOI:https://doi.org/10.1212/WNL.0000000000002560.
- Dong Y, Wu T, Hu X, et al. Efficacy and safety of botulinum toxin type a for upper limb spasticity after stroke or traumatic brain injury: a systematic review with meta-analysis and trial sequential analysis. Eur J Phys Rehabil Med. 2017;53(2):256–267. DOI:https://doi.org/10.23736/S1973-9087.16.04329-X.
- Simpson DM, Gracies JM, Yablon SA, et al. Botulinum neurotoxin versus tizanidine in upper limb spasticity: a placebo-controlled study. J Neurol Neurosurg Psychiatry. 2009;80(4):380–385. DOI:https://doi.org/10.1136/jnnp.2008.159657.
- van Kuijk AA, Geurts AC, Bevaart BJ, et al. Treatment of upper extremity spasticity in stroke patients by focal neuronal or neuromuscular blockade: a systematic review of the literature. J Rehabil Med. 2002;34(2):51–61. DOI:https://doi.org/10.1080/165019702753557836.
- Brashear A, Zafonte R, Corcoran M, et al. Inter- and intrarater reliability of the Ashworth scale and the disability assessment scale in patients with upper-limb poststroke spasticity. Arch Phys Med Rehabil. 2002;83(10):1349–1354. DOI:https://doi.org/10.1053/apmr.2002.35474.
- Baker JA, Pereira G. The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: a systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach. Clin Rehabil. 2015;29(8):731–740.
- Baker JA, Pereira G. The efficacy of Botulinum Toxin A for limb spasticity on improving activity restriction and quality of life: a systematic review and meta-analysis using the GRADE approach. Clin Rehabil. 2016;30(6):549–558.
- Wein T, Esquenazi A, Jost WH, et al. Onabotulinumtoxin A for the treatment of Poststroke distal lower limb spasticity: a randomized trial. PM R. 2018;10(7):693–703. DOI:https://doi.org/10.1016/j.pmrj.2017.12.006.
- Esquenazi A, Wein TH, Ward AB, et al. Optimal muscle selection for onabotulinumtoxin A injections in poststroke lower-limb spasticity: a randomized trial. Am J Phys Med Rehabil. 2019;98(5):360–368. DOI:https://doi.org/10.1097/PHM.0000000000001101.
- Kaji R, Osako Y, Suyama K, et al. Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial. J Neurol. 2010;257(8):1330–1337. DOI:https://doi.org/10.1007/s00415-010-5526-3.
- Thanikachalam V, Phadke CP, Ismail F, et al. Effect of Botulinum toxin on clonus: a systematic review. Arch Phys Med Rehabil. 2017;98(2):381–390. DOI:https://doi.org/10.1016/j.apmr.2016.09.126.
- Finnerup NB. Neuropathic pain and spasticity: intricate consequences of spinal cord injury. Spinal Cord. 2017;55(12):1046–1050.
- Picelli A, Bonetti P, Fontana C, et al. Accuracy of botulinum toxin type a injection into the gastrocnemius muscle of adults with spastic equinus: manual needle placement and electrical stimulation guidance compared using ultrasonography. J Rehabil Med. 2012;44(5):450–452. DOI:https://doi.org/10.2340/16501977-0970.
- Grigoriu AI, Dinomais M, Rémy-Néris O, et al. Impact of injection-guiding techniques on the effectiveness of Botulinum toxin for the treatment of focal spasticity and dystonia: a systematic review. Arch Phys Med Rehabil. 2015;96(11):2067–2078. DOI:https://doi.org/10.1016/j.apmr.2015.05.002.
- Comella CL, Buchman AS, Tanner CM, et al. Botulinum toxin injection for spasmodic torticollis: increased magnitude of benefit with electromyographic assistance. Neurology. 1992;42(4):878–882. DOI:https://doi.org/10.1212/WNL.42.4.878.
- Chin TY, Nattrass GR, Selber P, et al. Accuracy of intramuscular injection of botulinum toxin a in juvenile cerebral palsy: a comparison between manual needle placement and placement guided by electrical stimulation. J Pediatr Orthop. 2005;25(3):286–291. DOI:https://doi.org/10.1097/01.bpo.0000150819.72608.86.
- Picelli A, Lobba D, Midiri A, et al. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques. Clin Rehabil. 2014;28(3):232–242. DOI:https://doi.org/10.1177/0269215513497735.
- Santamato A, Micello MF, Panza F, et al. Can botulinum toxin type a injection technique influence the clinical outcome of patients with post-stroke upper limb spasticity? A random-ized controlled trial comparing manual needle placement and ultrasound-guided injection techniques. J Neurol Sci. 2014;347(1–2):39–43. DOI:https://doi.org/10.1016/j.jns.2014.09.016.
- Turna IF, Erhan B, Gunduz NB, et al. The effects of different injection techniques of botulinum toxin a in post-stroke patients with plantar flexor spasticity. Acta Neurol Belg. 2020;120(3):639–643. DOI:https://doi.org/10.1007/s13760-018-0969-x.
- Picelli A, Tamburin S, Bonetti P, et al. Botulinum toxin type A injection into the gastrocnemius muscle for spastic equinus in adults with stroke: a randomized controlled trial comparing manual needle placement, electrical stimulation and ultrasonography-guided injection techniques. Am J Phys Med Rehabil. 2012;91(11):957–964. DOI:https://doi.org/10.1097/PHM.0b013e318269d7f3.
- Zeuner KE, Knutzen A, Kuhl C, et al. Functional impact of different muscle localization techniques for Botulinum neurotoxin a injections in clinical routine management of post-stroke spasticity. Brain Inj. 2017;31(1):75–82. DOI:https://doi.org/10.1080/02699052.2016.1218545.
- Jankovic J, Truong D, Patel AT, et al. Injectable DaxibotulinumtoxinA in cervical dystonia: a phase 2 dose-escalation multicenter study. Mov Disord Clin Pract. 2018;5(3):273–282. DOI:https://doi.org/10.1002/mdc3.12613.
- Hassell TJW, Charles D. Treatment of blepharospasm and oromandibular dystonia with botulinum toxins. Toxins (Basel). 2020;12(4):269.
- Bertucci V, Solish N, Kaufman-Janette J, et al. DaxibotulinumtoxinA for Injection has a prolonged duration of response in the treatment of glabellar lines: pooled data from two multicenter, randomized, double-blind, placebo-controlled, phase 3 studies (SAKURA 1 and SAKURA 2). J Am Acad Dermatol. 2020;82(4):838–845. DOI:https://doi.org/10.1016/j.jaad.2019.06.1313.
- Tang X, Wan X. Comparison of Botox with a Chinese type A botulinum toxin. Chin Med J (Engl). 2000;113(9):794–798.
- Quagliato EM, Carelli EF, Viana MA. A prospective, randomized, double-blind study comparing the efficacy and safety of type a botulinum toxins botox and prosigne in the treatment of cervical dystonia. Clin Neuropharmacol. 2010;33(1):22–26.
- Rieder CR, Schestatsky P, Socal MP, et al. A double-blind, randomized, crossover study of prosigne versus botox in patients with blepharospasm and hemifacial spasm. Clin Neuropharmacol. 2007;30(1):39–42. DOI:https://doi.org/10.1097/01.WNF.0000236771.77021.3C.
- Yoon JS, Kim JC, Lee SY. Double-blind, randomized, comparative study of Meditoxin versus Botox in the treatment of essential blepharospasm. Korean J Ophthalmol. 2009;23(3):137–141.
- Sane S, Ali MJ, Naik MN. Comparison of safety and efficacy of botox and neuronox in the management of benign essential blepharospasm: a split-face study. Korean J Ophthalmol. 2019;33(5):430–435.
- Spiegel LL, Ostrem JL, Bledsoe IO. FDA approvals and consensus guidelines for botulinum toxins in the treatment of dystonia. Toxins (Basel). 2020;12(5):332.
- Simpson DM, Alexander DN, O’Brien CF, et al. Botulinum toxin type A in the treatment of upper extremity spasticity: a randomized, double-blind, placebo-controlled trial. Neurology. 1996;46(5):1306–1310. DOI:https://doi.org/10.1212/WNL.46.5.1306.
- Hyman N, Barnes M, Bhakta B, et al. Botulinum toxin (Dysport) treatment of hip adductor spasticity in multiple sclerosis: a prospective, randomised, double blind, placebo controlled, dose ranging study. J Neurol Neurosurg Psychiatry. 2000;68(6):707–712. DOI:https://doi.org/10.1136/jnnp.68.6.707.
- Nalysnyk L, Papapetropoulos S, Rotella P, et al. Onabotulinumtoxin A muscle injection patterns in adult spasticity: a systematic literature review. BMC Neurol. 2013;13(1):118. DOI:https://doi.org/10.1186/1471-2377-13-118.
- Schramm A, Ndayisaba JP, Dem Brinke M A, et al. Spasticity treatment with onabotulinumtoxin A: data from a prospective German real-life patient registry. J Neural Transm (Vienna). 2014;121(5):521–530. DOI:https://doi.org/10.1007/s00702-013-1145-3.
- Wissel J. Towards flexible and tailored botulinum neurotoxin dosing regimens for focal dystonia and spasticity—insights from recent studies. Toxicon. 2018;147:100–106.
- Bensmail D, Hanschmann A, Wissel J. Satisfaction with botulinum toxin treatment in post-stroke spasticity: results from two cross-sectional surveys (patients and physicians). J Med Econ. 2014;17(9):618–625.
- Abo M, Shigematsu T, Hara H, et al. Efficacy and safety of Onabotulinumtoxin A 400 units in patients with post-stroke upper limb spasticity: final report of a randomized, double-blind, placebo-controlled trial with an open-label extension phase. Toxins (Basel). 2020;12(2):127. DOI:https://doi.org/10.3390/toxins12020127.
- Doan TN, Kuo MY, Chou LW. Efficacy and optimal dose of botulinum toxin a in post-stroke lower extremity spasticity: a systematic review and meta-analysis. Toxins (Basel). 2021;13(6):428.
- Mills PB, Finlayson H, Sudol M, et al. Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity. Clin Rehabil. 2016;30(6):537–548. DOI:https://doi.org/10.1177/0269215515593783.
- Intiso D, Santamato A, Di Rienzo F, et al. Effect of electrical stimulation as an adjunct to botulinum toxin type a in the treatment of adult spasticity: a systematic review. Disabil Rehabil. 2017;39(21):2123–2133. DOI:https://doi.org/10.1080/09638288.2016.1219398.
- Ip AH, Phadke CP, Boulias C, et al. Practice patterns of physicians using adjunct therapies with botulinum toxin injection for spasticity: a Canadian multicenter cross-sectional survey. PM R. 2021;13(4):372–378. DOI:https://doi.org/10.1002/pmrj.12442.
- Picelli A, Santamato A, Chemello E, et al. Adjuvant treatments associated with botulinum toxin injection for managing spasticity: an overview of the literature. Ann Phys Rehabil Med. 2019;62(4):291–296. DOI:https://doi.org/10.1016/j.rehab.2018.08.004.
- Lee JM, Gracies JM, Park SB, et al. Botulinum toxin injections and electrical stimulation for spastic paresis improve active hand function following stroke. Toxins (Basel). 2018;10(11):426. DOI:https://doi.org/10.3390/toxins10110426.
- Santamato A, Micello MF, Panza F, et al. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial. Clin Rehabil. 2015;29(1):50–58. DOI:https://doi.org/10.1177/0269215514537915.
- Carda S, Invernizzi M, Baricich A, et al. Casting, taping or stretching after botulinum toxin type A for spastic equinus foot: a single-blind randomized trial on adult stroke patients. Clin Rehabil. 2011;25(12):1119–1127. DOI:https://doi.org/10.1177/0269215511405080.
- Baricich A, Carda S, Bertoni M, et al. A single-blinded, randomized pilot study of botulinum toxin type A combined with non-pharmacological treatment for spastic foot. J Rehabil Med. 2008;40(10):870–872. DOI:https://doi.org/10.2340/16501977-0251.
- Maulet T, Pouplin S, Bensmail D, et al. Self-rehabilitation combined with botulinum toxin to improve arm function in people with chronic stroke. A randomized controlled trial. Ann Phys Rehabil Med. 2021;64(4):101450. DOI:https://doi.org/10.1016/j.rehab.2020.10.004.
- Sun SF, Hsu CW, Sun HP, et al. Combined botulinum toxin type A with modified constraint-induced movement therapy for chronic stroke patients with upper extremity spasticity: a randomized controlled study. Neurorehabil Neural Repair. 2010;24(1):34–41. DOI:https://doi.org/10.1177/1545968309341060.
- Erbil D, Tugba G, Murat TH, et al. Effects of robot-assisted gait training in chronic stroke patients treated by botulinum toxin-a: a pivotal study. Physiother Res Int. 2018;23(3):e1718. DOI:https://doi.org/10.1002/pri.1718.
- Pennati GV, Da Re C, Messineo I, et al. How could robotic training and botulinum toxin be combined in chronic post stroke upper limb spasticity? A pilot study. Eur J Phys Rehabil Med. 2015;51(4):381–387.
- Abramovich SG, Drobyshev VA, Pyatova AE, et al. Comprehensive use of dynamic electrical neurostimulation and botulinum toxin therapy in patients with post-stroke spasticity. J Stroke Cerebrovasc Dis. 2020;29(11):105189. DOI:https://doi.org/10.1016/j.jstrokecerebrovasdis.2020.105189.
- Karadag-Saygi E, Cubukcu-Aydoseli K, Kablan N, et al. The role of kinesiotaping combined with botulinum toxin to reduce plantar flexors spasticity after stroke. Top Stroke Rehabil. 2010;17(4):318–322. DOI:https://doi.org/10.1310/tsr1704-318.
- Hara T, Momosaki R, Niimi M, et al. Botulinum toxin therapy combined with rehabilitation for stroke: a systematic review of effect on motor function. Toxins (Basel). 2019;11(12):707. DOI:https://doi.org/10.3390/toxins11120707.
- Meythaler JM, Clayton W, Davis LK, et al. Orally delivered baclofen to control spastic hypertonia in acquired brain injury. J Head Trauma Rehabil. 2004;19(2):101–108. DOI:https://doi.org/10.1097/00001199-200403000-00003.
- Leary SM, Gilpin P, Lockley L, et al. Intrathecal baclofen therapy improves functional intelligibility of speech in cerebral palsy. Clin Rehabil. 2006;20(3):228–231. DOI:https://doi.org/10.1191/0269215506cr940oa.
- Krause T, Gerbershagen MU, Fiege M, et al. Dantrolene ? A review of its pharmacology, therapeutic use and new developments. Anaesthesia. 2004;59(4):364–373. DOI:https://doi.org/10.1111/j.1365-2044.2004.03658.x.
- Stamenova P, Koytchev R, Kuhn K, et al. A randomized, double-blind, placebo-controlled study of the efficacy and safety of tolperisone in spasticity following cerebral stroke. Eur J Neurol. 2005;12(6):453–461. DOI:https://doi.org/10.1111/j.1468-1331.2005.01006.x.
- Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical Use: a Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473. DOI:https://doi.org/10.1001/jama.2015.6358.
- Agarwal S, Patel T, Shah N, et al. Comparative study of therapeutic response to baclofen vs tolperisone in spasticity. Biomed Pharmacother. 2017;87:628–635.
- Olvey EL, Armstrong EP, Grizzle AJ. Contemporary pharmacologic treatments for spasticity of the upper limb after stroke: a systematic review. Clin Ther. 2010;32(14):2282–2303.
- Lindsay C, Kouzouna A, Simcox C, et al. Pharmacological interventions other than botulinum toxin for spasticity after stroke. Cochrane Database Syst Rev. 2016;10:CD010362.
- Winstein CJ, Stein J, Arena R, et al. Guidelines for adult stroke rehabilitation and recovery: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2016;47(6):e98–e169. DOI:https://doi.org/10.1161/STR.0000000000000098.
- Kirazli Y, On AY, Kismali B, et al. Comparison of phenol block and botulinum toxin type a in the treatment of spastic foot after stroke: a randomized, double-blind trial. Am J Phys Med Rehabil. 1998;77(6):510–515. DOI:https://doi.org/10.1097/00002060-199811000-00012.
- Chua KS, Kong KH. Alcohol neurolysis of the sciatic nerve in the treatment of hemiplegic knee flexor spasticity: clinical outcomes. Arch Phys Med Rehabil. 2000;81(10):1432–1435.
- Kocabas H, Salli A, Demir AH, et al. Comparison of phenol and alcohol neurolysis of tibial nerve motor branches to the gastrocnemius muscle for treatment of spastic foot after stroke: a randomized controlled pilot study. Eur J Phys Rehabil Med. 2010;46(1):5–10.
- Karri J, Mas MF, Francisco GE, et al. Practice patterns for spasticity management with phenol neurolysis. J Rehabil Med. 2017;49(6):482–488. DOI:https://doi.org/10.2340/16501977-2239.
- Wissel J, Müller J, Heinen F, et al. Safety and tolerance of single-dose botulinum toxin Type A treatment in 204 patients with spasticity and localized associated symptoms. Austrian and German botulinum toxin A spasticity study group. Wien Klin Wochenschr. 1999;111(20):837–842. German.
- Petrillo CR, Knoploch S. Phenol block of the tibial nerve for spasticity: a long-term follow-up study. Int Disabil Stud. 1988;10(3):97–100.
- Bodine-Fowler SC, Allsing S, Botte MJ. Time course of muscle atrophy and recovery following a phenol-induced nerve block. Muscle Nerve. 1996;19(4):497–504.
- Garcia LC, Alcântara CC, Santos GL, et al. Cryotherapy reduces muscle spasticity but does not affect proprioception in ischemic stroke: a randomized sham-controlled crossover study. Am J Phys Med Rehabil. 2019;98(1):51–57. DOI:https://doi.org/10.1097/PHM.0000000000001024.
- Allison SC, Abraham LD. Sensitivity of qualitative and quantitative spasticity measures to clinical treatment with cryotherapy. Int J Rehabil Res. 2001;24(1):15–24.
- Alcantara CC, Blanco J, De Oliveira LM, et al. Cryotherapy reduces muscle hypertonia, but does not affect lower limb strength or gait kinematics post-stroke: a randomized controlled crossover study. Top Stroke Rehabil. 2019;26(4):267–280. DOI:https://doi.org/10.1080/10749357.2019.1593613.
- Meythaler JM, Guin-Renfroe S, Brunner RC, et al. Intrathecal baclofen for spastic hypertonia from stroke. Stroke. 2001;32(9):2099–2109. DOI:https://doi.org/10.1161/hs0901.095682.
- Francisco GE, Yablon SA, Schiess MC, et al. Consensus panel guidelines for the use of intrathecal baclofen therapy in poststroke spastic hypertonia. Top Stroke Rehabil. 2006;13(4):74–85. DOI:https://doi.org/10.1310/tsr1304-74.
- Saulino M, Anderson DJ, Doble J, et al. Best practices for Intrathecal baclofen therapy: troubleshooting. Neuromodulation. 2016;19(6):632–641. DOI:https://doi.org/10.1111/ner.12467.
- Creamer M, Cloud G, Kossmehl P, et al. Intrathecal baclofen therapy versus conventional medical management for severe poststroke spasticity: results from a multicentre, randomised, controlled, open-label trial (SISTERS). J Neurol Neurosurg Psychiatry. 2018;89(6):642–650. DOI:https://doi.org/10.1136/jnnp-2017-317021.
- Sindou MP, Mertens P. Neurosurgery for spasticity. Stereotact Funct Neurosurg. 2000;74(3–4):217–221.
- Duquette SP, Adkinson JM. Surgical management of spasticity of the forearm and wrist. Hand Clinics. 2018;34(4):487–502. DOI:https://doi.org/10.1016/j.hcl.2018.06.006.
- Sturbois-Nachef N, Allart E, Grauwin M-Y, et al. Tibialis posterior transfer for foot drop due to central causes: long-term hindfoot alignment. Orthop Traumatol Surg Res. 2019;105(1):153–158. DOI:https://doi.org/10.1016/j.otsr.2018.11.013.